ArticleJournal of diabetes and metabolic disorders2023
A cost-effectiveness analysis of linagliptin add-on to insulin treatment for patients with type 2 diabetes mellitus and chronic kidney disease in Iran.
Soroush Ahmadi Fariman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.